Biodegradable Microneedle Drug Delivery Patches
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
54
NCT05525650
Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 20, 2022
Completion: Jun 15, 2025
Loading map...